India IPO SEBI DRHP Activity Filings — October 31, 2026
The India IPO Activity Monitor for 31-Oct-2026 captures two post-listing disclosures that reveal a stark divergence in SME IPO quality: Broach Lifecare Hospital (allotted Aug-2024) shows disciplined, near-complete deployment of its ₹402 Lakh issue with no deviation, while Finelistings Technologies (allotted May-2024) reports a sharp deterioration in financial performance despite full deployment of its ₹1,243 Lakh issue. Finelistings' H1 FY27 revenue of ₹407.87 Lakh is down ~32% versus the prior full-year ₹600.87 Lakh (not directly comparable but directionally weak), and it swung to a net loss of ₹143.39 Lakh from a profit of ₹30.31 Lakh, with EPS collapsing to ₹(4.02) from ₹5.21. Shareholders' funds fell 13.6% to ₹939.86 Lakh as reserves eroded by ₹148.39 Lakh, signaling balance-sheet stress. In contrast, Broach has fully utilized general corporate and issue expenses and deployed 74% of machinery capex, with only the medical tourism portal lagging at 64% completion. The filings underscore a key theme: IPO proceeds alone do not guarantee post-listing performance, and investors must track utilization quality and operational execution. With no insider activity or forward guidance disclosed, the focus remains on deployment milestones and the upcoming H2 FY27 results as the next catalyst.